2.0
Aug 16, 2013
Recommend
CEO approval
Business Outlook
Pros
Many smart scientists still work at Merck, especially below the Executive Director, and probably below the Director levels.
Cons
Instability over the last 5 years that leads to direction changes every 8 months (especially in Oncology). Complete incompetence and lack of any vision at the highest management levels (people like Rich Tillyer) -- they use the company to exercise their huge egos, while destroying any real science and innovation. A lot of incompetence at the lower management levels (Executive Directors, Directors). Extreme inefficiency of the decision making process -- all power brokers need to be satisfied, leading to bad decisions. Good scientist and good science are not respected.
